Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
28,700
Total Claims
$1.7M
Drug Cost
760
Beneficiaries
$2,283
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+118%
Opioid rate vs peers
4.9% vs 2.2% avg
+62%
Cost per patient vs peers
$2,283 vs $1,411 avg
+7%
Brand preference vs peers
11.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.9%
Opioid Rate
1,398
Opioid Claims
$35K
Opioid Cost
3.3%
Long-Acting Rate
Brand vs Generic
Brand: 3,251 claims · $1.3M
Generic: 25,212 claims · $447K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 468 | $190K |
| Sacubitril/Valsartan | 169 | $91K |
| Dapagliflozin Propanediol | 48 | $56K |
| Dulaglutide | 51 | $52K |
| Emtricitab/Rilpiviri/Tenof Ala | 13 | $48K |
| Insulin Glargine,hum.Rec.Anlog | 83 | $47K |
| Empagliflozin | 67 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 84 | $40K |
| Sitagliptin Phosphate | 84 | $37K |
| Semaglutide | 36 | $35K |
| Insulin Detemir | 45 | $34K |
| Linaclotide | 74 | $33K |
| Rivaroxaban | 89 | $33K |
| Linagliptin | 58 | $26K |
| Insulin Aspart | 57 | $25K |
Prescribing Profile
Patient Profile
73
Avg Age
55%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About